Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Fluorescent Calcium-Activated Potassium Channel KCa3.1 and its Interactions with Peptide Blockers

  1. 1Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia
  2. 2Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia

Abstract

The intermediate-conductance Ca2+-activated potassium channel KCa3.1 plays a crucial role in various cellular processes and is implicated in the pathogenesis of neuroimmune, inflammatory, cardiovascular, and oncological diseases. Pore blockers of KCa3.1 are promising therapeutic candidates and valuable tools for studying the structure and function of the channel. However, little data is available on the activity of potassium channel blockers against the KCa3.1 channel. To address this issue, a fluorescent cellular system was created to search for and study blockers that bind to the outer vestibule of the KCa3.1 pore. It comprises mammalian cells expressing mKate2-tagged KCa3.1 channels, a fluorescent ligand (charybdotoxin conjugated with Atto488), and a competitive binding procedure to measure the affinity of non-fluorescent compounds for KCa3.1 using confocal microscopy. For KCa3.1, Atto488-charybdotoxin has a dissociation constant of 1.7 ± 0.3 nM, which is just slightly larger than the apparent dissociation constant of charybdotoxin (Kap = 1.09 ± 0.14 nM). Applying this cellular system, eight peptides were studied that were not previously characterized or tested only at low concentrations in relation to KCa3.1: Moka1, MeKTx11-1, hongotoxin 1, Ce1, Ce4, Ce5, scyllatoxin, and agitoxin 2. MeKTx11-1, Moka1, and hongotoxin 1 were found to bind (Kap of 13 ± 4, 21 ± 7, and 51 ± 9 nM, respectively) and block the KCa3.1 channel. No (or very weak) binding to KCa3.1 was observed for the other studied peptides, which, in particular, highlights the recently found high selectivity of Ce1 and Ce4 for the voltage-gated potassium Kv1.2 channel.

Related

  1. An Unbiased Drug Screen in a Drosophila Model of LMNA-Muscular Dystrophy Identifies Calcium Channel Blockers as Potential Treatments
    Nathaniel P. Mohar, Brenna A. Powers, Benjamin E. Hinz +7
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  2. LOca-1: A minimal calcium-activated arginyl-specific orthocaspase from the Loki's Castle hydrothermal vent field
    H. Arsın, P. Hribovsek, L. Urich +7
    bioRxivPreprintCC BYFull textMolecular biology & gene regulationbioRxiv
  3. Pathogenesis of Calcium Oxalate Kidney Stones, Interactions Among Mitochondria, NADPH Oxidase and Endoplasmic Reticulum
    Saeed R. Khan, Abdel A. Alli
    BiomoleculesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  4. Pyrrolocytosine as a Fluorescent Sensor of RNA-Small Molecule Interactions
    T. L. Coulson, G. A. Valdez, J. R. Widom
    bioRxivPreprintCC BY-NC-NDFull textBiophysicsbioRxiv
  5. Pyrrolocytosine as a Fluorescent Sensor of RNA–Small Molecule Interactions
    Taylor L. Coulson, Gavin A. Valdez, Julia R. Widom
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
BibTeX
@article{korabeynikova2026fluorescent,
  title = {{Fluorescent Calcium-Activated Potassium Channel KCa3.1 and its Interactions with Peptide Blockers}},
  author = {Varvara N. Korabeynikova and Ivan I. Shmatin and Mikhail P. Kirpichnikov and Oksana V. Nekrasova and Alexey V. Feofanov},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = nov,
  doi = {10.3390/ijms272210234},
  url = {https://www.mdpi.com/1422-0067/27/22/10234},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Fluorescent Calcium-Activated Potassium Channel KCa3.1 and its Interactions with Peptide Blockers
AU  - Varvara N. Korabeynikova
AU  - Ivan I. Shmatin
AU  - Mikhail P. Kirpichnikov
AU  - Oksana V. Nekrasova
AU  - Alexey V. Feofanov
PY  - 2026
DA  - 2026/11/15
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms272210234
UR  - https://www.mdpi.com/1422-0067/27/22/10234
AB  - The intermediate-conductance Ca2+-activated potassium channel KCa3.1 plays a crucial role in various cellular processes and is implicated in the pathogenesis of neuroimmune, inflammatory, cardiovascular, and oncological diseases. Pore blockers of KCa3.1 are promising therapeutic candidates and valuable tools for studying the structure and function of the channel. However, little data is available on the activity of potassium channel blockers against the KCa3.1 channel. To address this issue, a fluorescent cellular system was created to search for and study blockers that bind to the outer vestibule of the KCa3.1 pore. It comprises mammalian cells expressing mKate2-tagged KCa3.1 channels, a fluorescent ligand (charybdotoxin conjugated with Atto488), and a competitive binding procedure to measure the affinity of non-fluorescent compounds for KCa3.1 using confocal microscopy. For KCa3.1, Atto488-charybdotoxin has a dissociation constant of 1.7 ± 0.3 nM, which is just slightly larger than the apparent dissociation constant of charybdotoxin (Kap = 1.09 ± 0.14 nM). Applying this cellular system, eight peptides were studied that were not previously characterized or tested only at low concentrations in relation to KCa3.1: Moka1, MeKTx11-1, hongotoxin 1, Ce1, Ce4, Ce5, scyllatoxin, and agitoxin 2. MeKTx11-1, Moka1, and hongotoxin 1 were found to bind (Kap of 13 ± 4, 21 ± 7, and 51 ± 9 nM, respectively) and block the KCa3.1 channel. No (or very weak) binding to KCa3.1 was observed for the other studied peptides, which, in particular, highlights the recently found high selectivity of Ce1 and Ce4 for the voltage-gated potassium Kv1.2 channel.
SN  - 1422-0067
ER  -